Factors affecting the recurrence rate of basal cell carcinoma

Acta Dermato-Venereologica

Volumn 87, Issue 4, 2007, Pages 330-334

  Saabye Bøgelund, Fie ^a   Ashlede Philipsen, Peter ^a   Gniadecki, Robert ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Basal cell carcinoma; Curettage; Immunosuppression; Photodynamic therapy; Radiotherapy; Recurrence rate; Risk factors; Surgical excision

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CURETTAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RELAPSE; RISK; RISK FACTOR; SCALP TUMOR; TUMOR LOCALIZATION; CLINICAL COMPETENCE; DENMARK; DERMATOLOGY; FACE; HOSPITAL SUBDIVISIONS AND COMPONENTS; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDY; SCALP; SKIN TUMOR; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CLINICAL COMPETENCE; CURETTAGE; DENMARK; DERMATOLOGY; FACE; FEMALE; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; SCALP; SKIN NEOPLASMS;

EID: 35348882662     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0236     Document Type: Article

References (26)

1. Stockfleth E, Sterry W. New treatment modalities for basal cell carcinoma. Recent Results Cancer Res 2002; 160: 259-268.
2. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004; 329: 705.
3. Netscher DT, Spira M. Basal cell carcinoma: an overview of tumor biology and treatment. Plast Reconstr Surg 2004; 113: 74E-94E.
4. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141: 415-423.
5. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991; 17: 720-726.
6. Helsing P, Kramer P, Haugstvedt A, Aarebrot S, Todal A, Moseng D, Loeb M. Kirurgisk behandling av basalcellekarsinomer. [Surgical treatment of basal cell carcinoma]. Tidsskr Nor Laegeforen 2004; 124: 2740-2742.
7. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992; 18: 471-476.
8. Lovatt TJ, Lear JT, Bastrilles J, Wong C, Griffiths CE, Samarasinghe V, et al. Associations between ultraviolet radiation, basal cell carcinoma site and histology, host characteristics, and rate of development of further tumors. J Am Acad Dermatol 2005; 52: 468-473.
9. Weimar VM, Ceilley RI, Goeken JA. Aggressive biologic behavior of basal- and squamous-cell cancers in patients with chronic lymphocytic leukemia or chronic lymphocytic lymphoma. J Dermatol Surg Oncol 1979; 5: 609-614.
10. Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, et al. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006; 142: 187-194.
11. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 2004; 151: 141-147.
12. Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364: 1766-1772.
13. Lawrence CM. Mohs' micrographic surgery for basal cell carcinoma. Clin Exp Dermatol 1999; 24: 130-133.
14. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999; 135: 1177-1183.
15. Kopf AW, Bart RS, Schrager D, Lazar M, Popkin GL. Curettage- electrodessication treatment of basal cell carcinomas. Arch Dermatol 1977; 113: 439-443.
16. Reymann F. Treatment of basal cell carcinoma of the skin with curettage. II. A follow-up study. Arch Dermatol 1973; 108: 528-531.
17. Barlow JO, Zalla MJ, Kyle A, DiCaudo DJ, Lim KK, Yiannias JA. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 2006; 54: 1039-1045.
18. Madan V, Hoban P, Strange RC, Fryer AA, Lear JT. Genetics and risk factors for basal cell carcinoma. Br J Dermatol 2006; 154 Suppl 1: 5-7.
19. Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76: 100-106.
20. Zagrodnik B, Kempf W, Seifert B, Muller B, Burg G, Urosevic M, Dummer R. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003; 98: 2708-2714.
21. Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992; 18: 549-554.
22. Werlinger KD, Upton G, Moore AY. Recurrence rates of primary non-melanoma skin cancers treated by surgical excision compared to electrodessication- curettage in a private dermatological practice. Dermatol Surg 2002; 28: 1138-1142.
23. Alexiades-Armenakas M, Ramsay D, Kopf AW. The appropriateness of curettage and electrodesiccation for the treatment of basal cell carcinomas. Arch Dermatol 2000; 136: 800.
24. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-840.
25. Naidenov N, Dencheva R, Tsankov N. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy. Acta Dermatovenerol Croat 2004; 12: 157-161.
26. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001; 145: 467-471.